Le Lézard5h
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...
Verywell Health on MSN7h
4 Natural Remedies That May Help With Allergic Asthma Symptoms
People with allergic asthma may benefit from natural remedies such as avoiding triggers, reducing stress, and an ...
Medindia16h
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
New�Analyses from the Phase 3 ASPEN Study Examining Efficacy and Safety of Brensocatib Across a Variety of Prespecified Subgroups� �Data on Health Status Improvements Over Time Following Culture ...
Hackney Gazette19h
Health and Safety fine for Nofax for Dalston building site
Essex-based building contractor Nofax Enterprises has been fined by a judge for exposing workers at a construction site in Dalston to dangerous ...
Rheumatology Advisor16h
Interstitial Lung Abnormalities in PRISm Linked to Greater Mortality Risk
Interstitial lung abnormalities are more prevalent in individuals with PRISm, and those with PRISm and ILAs have higher all-cause mortality.
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates
Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio" or the "Company"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today ...